Spyre Therapeutics, Inc. SYRE

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-04-07 · LEI

Spyre Therapeutics, Inc. institutional holders

Investor	Shares	Value	% of company
BlackRock Finance, Inc.	2,403,441	$56.5M	3.07%
MILLENNIUM MANAGEMENT LLC	146,639	$7.4M	0.19%
CITADEL ADVISORS LLC	123,435	$6.2M	0.16%
AQR CAPITAL MANAGEMENT LLC	20,874	$1.1M	0.03%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.